Principal Securities »

Skye Bioscience shares owned by Principal Securities

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by Principal Securities from 13F filings

Historical chart of Principal Securities investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by Principal Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by Principal Securities

Quarter filed Position value Share count Share price at filing
2024-09-30 $8 2 4.00
2024-06-30 $16 2 8.00

More positions owned by Principal Securities

Principal Exchange Traded Us Mega Cp Etf (USMC)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Goldman Sachs Etf Tr Marketbeta Us Eq (GSUS)
Principal Exchange Traded Prin U S Small (PSC)
Microsoft Corporation (MSFT)
Principal Exchange Traded Focused Blue Chi (BCHP)
Ishares Tr Rus 1000 Etf (IWB)
Amazon (AMZN)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Apple (AAPL)
Principal Exchange Traded Prnc Invt Grad (IG)
Principal Exchange Traded Prncpl Vlu Etf (PY)
Goldman Sachs Etf Tr Activebeta Int (GSIE)

View all positions for Principal Securities

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Baker Bros. Advisors
BlackRock
Schonfeld Strategic Advisors
Ensign Peak Advisors
Driehaus Capital Management
Alyeska Investment Group
Platinum Investment Mangement
Point72 Asset Management
AWM Investment Company
Geode Capital Management
Mirae Asset Global Etfs Holdings
Citadel Advisors
Northern Trust

View all funds holding Skye Bioscience